IceCure Medical Total Long-Term Assets 2020-2024 | ICCM
IceCure Medical total long-term assets from 2020 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
| IceCure Medical Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $2 |
| 2022 | $2 |
| 2021 | $2 |
| 2020 | $1 |
| 2019 | $0 |
| IceCure Medical Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-03-31 | $2 |
| 2023-03-31 | $2 |
| 2022-03-31 | $2 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | |
| 2020-12-31 | $1 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.064B | $0.003B |
| IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. | |||